Ticagrelor Versus Clopidogrel in Large Vessel Ischemic Stroke

PHASE3CompletedINTERVENTIONAL
Enrollment

580

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

September 1, 2023

Study Completion Date

November 1, 2023

Conditions
Ischemic Stroke
Interventions
DRUG

Ticagrelor 90 MG

Efficacy and safety of 180 mg loading dose of ticagrelor administered within 24 hours of first-ever ischemic stroke followed by 90 mg bid for 3 months will be assessed through NIHSS, mRS, duration of hospital stay, new ischemic stroke, and possible adverse effects.

DRUG

Clopidogrel

Efficacy and safety of 300 mg clopidogrel followed by 75 mg once daily for 3 months will be assessed through NIHSS, mRS, duration of hospital stay, new ischemic stroke, and possible adverse effects.

Trial Locations (1)

33511

Kafr Elsheikh University Hospital, Kafr ash Shaykh

All Listed Sponsors
lead

Kafrelsheikh University

OTHER

NCT06120725 - Ticagrelor Versus Clopidogrel in Large Vessel Ischemic Stroke | Biotech Hunter | Biotech Hunter